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Abstract: The USDA/APHIS/Wildlife Services (WS) oral rabies vaccination program uses
tetracycline, a broad-spectrum antibiotic and relatively reliable biomarker, to quantify vaccinebait uptake by raccoons (Procyon lotor). However, obtaining samples (e.g., bone or teeth) to
assess tetracycline uptake is highly invasive, and sample preparation can be expensive. By
contrast, rhodamine B, a commercially available dye, is absorbed systemically in growing
tissues, including hair and whiskers, and can be observed under ultraviolet (UV) light as
fluorescent orange bands. Our goal was to evaluate whether rhodamine B can be used as a
biomarker to monitor bait uptake by raccoons. We began by orally administering a solution
containing 100 mg, 150 mg, or 200 mg of rhodamine B to captive raccoons. We monitored
whisker and hair samples for fluorescence using a hand-held UV lamp and a fluorescent
microscope for 13-weeks post-treatment. All raccoons that were administered rhodamine
B exhibited fluorescence in their whisker and hair samples during the course of the study.
Our ability to detect fluorescing whiskers varied based on the method of detection and time
interval, but not with rhodamine B dosage level. We detected rhodamine B in 81% of marked
individuals using the fluorescent microscope and 58% of marked subjects using the UV lamp.
We were able to detect rhodamine B when doses as low as 1 mg/kg were given. Raccoons did
not exhibit a taste aversion to baits containing ≤3% rhodamine B. We believe that rhodamine
B can be a useful biomarker for raccoons and has potential as an application to monitor the
uptake of oral rabies vaccine.
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B3+,+.3%1, 01'E#'6 (i.e., biomarkers) cause
alterations in baseline cellular, biochemical, or
molecular characteristics that can be used to
identify when an event or physiological process
of interest has occurred in an individual. In
wildlife disease management, biomarkers have
been used to provide evidence of exposure
to vaccine baits. The purpose of distributing
vaccine baits is to lower the proportion of
susceptible (i.e., nonvaccinated) animals in a
population so that the probability of an infected
animal encountering and infecting a susceptible
animal becomes too low to maintain the chain
of infection. Generally, vaccination coverage
of 70% is considered suﬃcient to break
disease transmission cycles (Hethcote 1978). A
biomarker‑based baiting strategy, such as that
used by the U.S. Department of Agriculture,
Wildlife Services’ (WS) national oral rabies
vaccination program, should include a post‑
hoc assessment of bait uptake, followed by
additional bait deployment if vaccination
coverage is determined to be <70%. For such a

strategy to be successful, timely information on
bait uptake is essential.
Wildlife
Services
has
incorporated
tetracycline as a biomarker in bait blocks used
to distribute the RABORAL V‑RG® (Merial,
Ltd., Duluth, Ga.) oral rabies vaccine to
raccoons since 1990. Tetracycline chelates with
calcium ions in teeth and bones and produces
a ﬂuorescent mark under ultra‑violet (UV)
light (Savarie et al. 1992). Although tetracycline
has proven to be a reliable biomarker for bait
consumption, several concerns exist regarding
its practicality (Fry and Dunbar 2007). First,
recovering samples from animals is laborious
and requires either euthanasia to retrieve a
bone sample or anesthesia to extract a tooth.
Second, sample preparation and analysis
are intensive processes requiring a highly‑
trained individual, diamond‑blade saw, and a
ﬂuorescent microscope (Johnston et al. 1999).
There also is controversy related to introducing
tetracycline into the environment. Wide‑
scale use of antibiotics has been linked to the
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development of antimicrobial resistance and
the perpetuation of antibiotic‑resistant genes
in bacteria (Levy 1998). Given those concerns, a
beeer biomarker is desirable.
Rhodamine B, a pink dye, has been used as
coloration of lipstick by the cosmetic industry,
in microscopy, and as a water‑tracing agent
(Smart 1984). Rhodamine B is used extensively
as a biomarker in Australia (Fisher et al.
1999), Africa (Knobel et al. 2002), and Europe
(Southey et al. 2002), and has been tested on a
number of wildlife species native to the United
States, including coyotes (Canis latrans; Johns
and Pan 1981), mountain beavers (Aplodontia
rufa; Lindsey 1983), and jackrabbits (Lepus
spp.; Evans and Griﬃth 1973). Rhodamine B,
like tetracycline, is deposited in annuli of teeth
(Ellenton and Johnston 1975) and can be used
to monitor serial exposure to baits, and oﬀers
several practical advantages over tetracycline.
Rhodamine B stains the buccal cavity and is
subsequently absorbed through diﬀusion in
growing keratinous tissues, such as nails, hair,
and whiskers (Clark 1953). Unlike tetracycline,
which requires tooth extraction, rhodamine
B requires a simple noninvasive procedure—
extraction of whiskers and hair—to detect its
presence. Moveover, whisker and hair samples
can easily be examined under UV light for
the presence of a ﬂuorescent orange band,
conﬁrming exposure to rhodamine B. Finally,
multiple exposures to rhodamine B, and, thus,
exposure to multiple baits over time, can be
observed as discrete ﬂuorescent bands in the
hair or whisker as long as they are growing
when rhodamine B is ingested.
We evaluated the utility of rhodamine B as a
biomarker to indicate bait uptake by raccoons
(Procyon lotor). Our objectives were to (1)
develop methods for sampling and evaluating
exposure to rhodamine B, (2) determine the
duration over which rhodamine B is detectable
in raccoons, and (3) identify a minimum dosage
that will mark raccoons.

Methods
We used Tomahawk™ box traps (Tomahawk
Live Trap Co., Tomahawk, Wis.) to capture
raccoons in Larimer County, Colorado, during
the spring of 2006 and the summer of 2007.
We transported captured individuals to the
Outdoor Animal Research Facility at the

National Wildlife Research Center (NWRC),
in Fort Collins, Colorado. Raccoons were held
in accordance with Institutional Animal Care
and Use Commieee guidelines under USDA‑
APHIS‑QA‑1410, QA‑1483, and QA‑1557. We
gave animals a health screening, administered
anti‑helmintic medication, and housed them
in 3‑ × 3‑ × 2.5‑m pens that included den boxes
and enrichment structures. We used raccoons
captured in the spring of 2006 (hereaHer, 2006
cohort) to identify sampling and evaluation
methodology and persistence of rhodamine B.
We used a second cohort of raccoons captured
in summer of 2007 (hereaHer, 2007 cohort) to
identify a minimum dosage and assess potential
taste aversion to rhodamine B.
To evaluate rhodamine B exposure and
extent of detectability evidence, we randomly
assigned 20 raccoons (14 females, 6 males) from
the 2006 cohort to 1 of 3 treatment groups (n
= 6 individuals per group) or a control group
(n = 2 individuals). We dissolved 23.3 mg of
rhodamine B in 1 ml of distilled water to create
an aqueous solution suitable for oral dosage and
evaluated which of 3 dosage levels (100 mg, 150
mg, and 200 mg; see Table 1 for corresponding
dosages) most eﬀectively marked raccoons. We
lightly sedated all raccoons using a mixture
of ketamine hydrochloride (10 mg/kg) and
xylazine hydrochloride (2 mg/kg), and used
a 10‑cc needleless syringe to administer oral
doses of the rhodamine B solution. Dosage by
weight ranged from 9.2 to 32.2 mg/kg, with
an average of 18.5 mg/kg (Table 1). We orally
dosed individuals assigned to the control
group with 6.4 ml of water. We chose to orally
dose raccoons, rather than allowing them to
ingest baits containing rhodamine B, because
our primary objective was to conﬁrm if speciﬁc
doses of rhodamine B marked raccoons. No
raccoons were observed to regurgitate the
rhodamine B solution.
Following the one‑time dosage event, we
restrained raccoons in a squeeze trap or other
appropriate device, and collected an average
of 3 whiskers (range 1–5) by plucking from
the root using forceps or needle‑nose pliers.
Plucking guaranteed that the entire whisker
was collected, a preferable option to cueing
which may result in the portion of the whisker
expressing ﬂuorescent bands being retained
by the raccoon. We also collected a small
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tuH of guard and body hairs to determine model estimation, Saeerthwaite’s F–tests to
if ﬂuorescence was detectable in these hair gauge eﬀects (McCullagh and Nelder 1989),
types. Our sampling began immediately and ﬁrst‑order autocorrelation as a covariance
prior to rhodamine B dosage (day 0) and structure. In all models, the proportion of
continued once a week for 13 weeks, a duration marked individuals was the response variable,
consistent with WS post oral rabies vaccination and individual nested within dosage level
sampling procedures. Because rhodamine B is was a random eﬀect. For our analysis of
detectable only in hair and whiskers that are ﬂuorescence in whiskers, dosage level (100, 150,
growing at the time of biomarker ingestion, or 200 mg of rhodamine B), sampling interval,
we minimized the number of whiskers and detection method (UV lamp or ﬂuorescent
collected on each sampling interval to ensure microscope) were ﬁxed eﬀects. For our analyses
that enough whiskers were available to last of guard and body hairs, detection method was
the duration of the study. For each individual omieed as a ﬁxed eﬀect; we were unable to
sampled, we examined all whisker and guard detect ﬂuorescing guard and body hairs using
and body hairs collected for ﬂuorescence. the UV lamp. We tested all 2‑way interactions
We prepared samples according to procedures of ﬁxed factors and made a posteriori pairwise
described by Fischer (1998). We ﬁxed cleaned comparisons using least squares means tests
hair and whiskers to a standard microscope (Zar 1999). Signiﬁcance for all tests was set
slide using Fluoromount‑G™ (SouthernBiotech, at an alpha of 0.05. We conducted a post‑hoc
Birmingham, Ala.), a water‑soluble, non‑ power analysis using data from the study to
ﬂuorescing compound for mounting slides. We assess the optimal number of whiskers needed
viewed slides using 2 methods: a handheld UV to detect exposure to rhodamine B. Using the
lamp with 3H magniﬁcation and 2 long‑wave conservative estimate that 58% (SD = 0.357) of
UV bulbs that emieed a wavelength of 365 whiskers from rhodamine‑B‑positive animals
nm at 20.3 cm (Q‑22B, Spectroline, Westbury, showed ﬂuorescence, we used the following
N.Y.); and under 2.5H magniﬁcation using a equation to determine sample size:
ﬂuorescent microscope comprised of a 100W
n = log (α) ÷ log (β)
high‑pressure mercury bulb and a rhodamine
(1)
ﬁlter block, TRITC (Leica, Germany). We used
the handheld UV lamp in a dark, windowless where α = 0.01, and β = 1‑ probability of
room. A single observer used both methods detecting ﬂuorescence (0.58).
to examine all samples for evidence of ﬂuor‑
At the conclusion of this component of the
escence. We calculated the proportion of study, raccoons from the 2006 cohort were
individuals whose whisker and hair samples immobilized with a mixture of ketamine
exhibited a ﬂuorescent band, and
Table 1: Rhodamine B dosage rates for raccoons. All doses
considered an individual marked marked raccoons.
when we detected a band on ≥1
Rhodamine B n
Minimum Maximum Average
whisker or hair.
dose
(mg/kg)
(mg/kg)
(mg/kg)
Proportional data were not
2
normally distributed, so we used an Control
arcsine‑root transformation to induce 200 mga
6
18.1
32.2
22.9
homoscedasticity (Smith 1976). We 150 mga
6
14.7
25.6
20.0
then used general linear mixed–
a
6
9.2
16.7
12.7
100 mg
models ANOVA to characterize
8
6.3
13.6
11.4
factors inﬂuencing the proportion 75 mg
of individuals exhibiting ﬂuorescent 50 mg
8
3.8
7.46
6.2
bands in whiskers and hairs. This
8
2.1
4.6
3.8
method enabled the ﬁeing of random 25 mg
terms and therefore accounted for 15 mg
8
1.5
2.25
2.2
repeated sampling across error
10 mg
8
1.0
1.4
1.2
terms. We used restricted maximum
likelihood (REML) methods for aRhodamine B dose volume was 23.3 mg/mL.

278

Human–Wildlife Interactions 4(2)

Figure 1: Proportion of racoons whose whiskers were marked by rhodamine B using both the UV microscope and a hand-held UV lamp over 13 weeks of sampling.

hydrochloride (10 mg/kg) and xylazine
hydrochloride (2 mg/kg), and euthanized
with an injection of Beuthanasia‑D Special
(0.25 m/kg; Schering‑Plough, Union, N.J.). A
veterinary pathologist at the Colorado State
University Veterinary Diagnostic Laboratory
necropsied all raccoons to assess possible
toxicological eﬀects of rhodamine B. Gross and
histopathological examination was conducted
on tissues, including, but not limited to, brain,
liver, thyroid, lung, lymph nodes, heart,
kidney, spleen, intestine, and stomach. We did
not sample blood, urine, and feces due to the
reported lack of persistence of rhodamine B in
these substances (Fisher 1998).
We used the 2007 cohort of 8 raccoons (2
females, 6 males) to identify a minimum
dosage eﬀective in marking raccoons, and
whether raccoons displayed a taste aversion
to rhodamine B. We added rhodamine B at
a concentration of 3% to the raccoon’s daily
kibble (Mazuri Omnivore diet A, PMI Nutrition
International, Shoreview, Minn.) by adding 3 g
of rhodamine B to every 100 g of ground kibble,
and reconstituted the mixture using water, corn
oil, and a minimal amount of ﬂour. We reformed
the kibble, dried it at room temperature for 3

days, and stored it under refrigeration until
used. We gave each raccoon the appropriate
mass of kibble to ensure that dosages of 75 mg,
50 mg, 25 mg, 15 mg, and 10 mg of rhodamine B
were ingested. Dosages were given a minimum
of 15 days apart, and all raccoons received the
same dosage level on the same day. Dosage
level was reduced sequentially to determine a
minimal eﬀective dose. We fed the rhodamine
B food between 0700–0900 hours and recorded
whether food had been consumed at 3‑hour
intervals for the ﬁrst 9 hours, and then at 24
hours.
We extracted 1 to 8 whiskers from each
raccoon 10 to 14 days aHer they had eaten food
containing rhodamine B. Allowing 10 to 14
days between rhodamine B consumption and
sampling was suﬃcient to create independent
bands in whiskers; thus, by the time raccoons
were oﬀered 10 mg of rhodamine B, 5 bands
were observable. We stored whiskers in plastic
zip‑lock bags, and prepared and evaluated
them as described above. We recorded data
on the number of positive whiskers using
both the hand‑held UV lamp and ﬂuorescent
microscope.
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Figure 2: Proportion of raccoons whose whiskers, guard hair, and body hair were marked by rhodamine B
using the UV microscope over 13 weeks of sampling.

Results

observed using the UV microscope (Figure 2).
For guard hairs, our ability to detect ﬂuorescent
bands diﬀered with dosage (F2,72.4 = 13.39,
P < 0.001) and week (F12,192 = 2.27, P = 0.01).
Least squares means tests indicated that the
proportion of ﬂuorescing samples from animals
receiving either 150 or 200 mg of rhodamine B
was greater than for those receiving a dose of
100 mg. For body hairs, our ability to detect
ﬂuorescent bands diﬀered with week (F12,193 =
4.03, P < 0.001) but not with dosage (F2,72.4 = 0.59,
P = 0.68).
All raccoons oﬀered varying doses of food
containing rhodamine B ingested the food
within 24 hours except in 2 cases. In those 2
situations, individuals did not consume food
containing 25 mg and 10 mg doses of rhodamine
B, and we did not see ﬂuorescent bands in the
whiskers in each of these 2 circumstances.
These 2 individuals consumed the food and
exhibited ﬂuorescence in their whiskers at all
other doses.

All raccoons fed rhodamine B (n = 18) showed
evidence (i.e., bands) of ﬂuorescence in their
whiskers, whereas the 2 control animals did
not. Our ability to detect ﬂuorescing whiskers
diﬀered relative to method of detection and
time interval (method H interval: F10,172 = 3.69,
P < 0.002; Figure 1), but not with dosage level
(F2,15.5 = 0.50, P = 0.61). On average, we were
able to detect ﬂuorescing whiskers in 81% and
58% of individuals sampled at each interval
when using the ﬂuorescent microscope and UV
lamp, respectively. The proportion of marked
individuals detected using the ﬂuorescent
microscope was consistently greater than with
the UV lamp, with the exception of weeks 12
and 13. At week 12, the proportion of marked
individuals detected using the microscope
declined by 50% from the previous interval,
but then increased by 47% during the next
week (Figure 1). When pooled across intervals
and among individuals, 50% of all individual
whiskers collected from treatment raccoons
Discussion
were positive for rhodamine B.
All raccoons that ingested rhodamine B
We were able to detect ﬂuorescence in guard were marked by the dye through ﬂuorescence
and body hairs with the microscope but not in their whiskers, regardless of dosage, and
with the UV lamp; thus, we report ﬂuorescence the mark persisted for at least 13 weeks. Our
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results indicate that, as a biomarker, rhodamine
B has several advantages over tetracycline,
including ease in evaluating presence, long‑
term persistence, detectability using minimally
invasive sampling methods, palatability, and
aﬀordability.
Analysis of methods used to evaluate
whiskers and hair for ﬂuorescence suggested
that ﬂuorescent microscopy was more successful
than the hand‑held UV lamp. Reliance solely
on a hand‑held UV lamp may result in
underestimating bait uptake, and trigger the
costly and unnecessary implementation of
additional baiting and vaccination campaigns.
Both methods, UV lamp and ﬂuorescent
microscope, have value and, when used in
concert, represent an improvement over
methods used to detect tetracycline uptake. The
cost and ease of using the hand‑held UV lamp
makes it an appropriate option for biologists
and managers in most ﬁeld applications,
whereas the precision of the ﬂuorescent
microscope allows for validation of samples
when necessary.
Although ﬂuorescent bands were detectable
in both body and guard hairs, whiskers
appear to be the beeer indicators of exposure
to rhodamine B and oﬀer several advantages
over hair samples. First, unlike body and guard
hairs, where growth is seasonal, whiskers grow
year‑round (Ling 1970), allowing biomarker
uptake to be determined over a continuous
temporal scale. Second, whiskers oHen are white
and, thus, easier to evaluate than the bicolor
body and guard hairs (Fisher 1998). Finally,
individual whiskers are larger than hairs and
easier to handle and prepare for microscopy.
A complicating factor in our study was that
sampling occurred weekly for 13 weeks, and
we collected a varying number of whiskers
resulting in varying sample eﬀort and repeated
sampling of the same individuals. This
intensive sampling increased the likelihood
that whiskers extracted from a given individual
were not growing when the animal ingested
rhodamine B, and, therefore, were not marked.
Our data indicate that it is necessary to collect 6
whiskers from an individual to determine with
99% conﬁdence whether a raccoon has been
exposed to rhodamine B.
Using a hand‑held UV lamp, we were able to
detect rhodamine B in samples for all animals
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that consumed food containing as liele as 10 mg
of the dye. The ability of low doses (e.g., 10 mg)
to consistently mark raccoons makes the dye
cost‑eﬀective and provides great potential for
inclusion in small baits and with medications
or vaccines. We did not randomly assign
individuals from the 2007 cohort to dosage
levels. Rather, individuals received each dosage
sequentially, to ensure that every dosage level
generated a ﬂuorescent band and that serial
exposure to baits was detectable. Rhodamine B
is absorbed instantaneously and, in turn, ﬂushed
from the system within 48 hours (Fisher 1998).
As a result, a ﬂuorescent band should represent
a discrete marker of a single dosing event. Our
results conﬁrm this notion: the 6 raccoons that
ate all 5 dosages had 5 ﬂuorescent bands visible
while the 2 raccoons that only ate 4 dosages had
4 bands visible at the conclusion of the study.
Unlike Hanlon et al. (1989), we found that
raccoons did not exhibit a taste aversion to
food containing rhodamine B. We believe the
divergent ﬁndings can be aeributed to the fact
that the rhodamine B concentration in baits
used by Hanlon et al. (1989) was greater than
the 3% concentration recommend to avoid taste
aversion (Fisher 1998). However, Hanlon et al.
(1989) reported that only 100 mg of rhodamine
B solution was oﬀered to raccoons in plastic
sachets, and no concentration was noted. Our
use of a 3% concentration was palatable to
raccoons and likely had the added beneﬁt of
minimizing adverse eﬀects on the environment,
as well as target and nontarget animals.
Rhodamine B is classiﬁed by the U.S.
Environmental Protection Agency as an inert
Class 4B substance, and concerns related to
its safety appear to be minimal (Clark 1953,
Gangolli et al. 1971, Ellioe et al. 1990, Fisher
1999). Research by Umeda (1956) suggests
that rhodamine B is carcinogenic. However,
that conclusion has been disputed (Goldberg
1967, Gangolli et al. 1971, International Agency
for the Research of Cancer 1978). Pathology
reports from the raccoons given 100 to 200 mg
of rhodamine B were comparable to control
raccoons, suggesting no deleterious eﬀects at
the dosages tested. All gross and histological
ﬁndings of raccoons were consistent with
diseases oHen found in free‑ranging raccoons
(Hamir et al. 1996, Mikaelian et al. 1999,
Yoshikawa et al. 1999), with no indication
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of pathological eﬀects due to exposure to
rhodamine B. Our ﬁnding of no immediate
pathological eﬀects is supported by others;
Ellioe et al. (1990) found no evidence that
rhodamine B was a genotoxic threat, and others
have found liele indication that rhodamine B
is mutagenic (Clark 1953, Fisher 1998). Finally,
the oral lethal dose (LD50) of rhodamine B is
>500 mg/kg in rats (Smart 1984) and 890 mg/kg
in mice (Rochat et al. 1979, Fisher 1998), well
below the dosage necessary to mark raccoons
as part of the oral vaccination program.

Management implications
The use of biomarkers in wildlife vaccination
programs is germane when information on
population‑level vaccine exposure is needed
for timely assessment of program success. Since
1995, the WS oral rabies vaccination (ORV)
program has used tetracycline as a biomarker
to evaluate vaccination bait uptake. However,
due to the logistics and cost of incorporating
tetracycline into baits, the ORV program has
been relegated to using tetracycline‑marked
baits in <50% of the ORV zones. Where
tetracycline has been used, the time lag between
laboratory submission and dissemination of
results (up to 18 months) prohibits timely
implementation of management actions. We
estimate the replacement of tetracycline with
rhodamine B can save the ORV program >$5
each time they aeempt to detect the biomarker.
Additionally, the use of hand‑held UV lamps to
measure population bait uptake will allow for
rapid evaluation and timely implementation
of supplemental baiting or other management
interventions.
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